KELLY MARTIN: Open Payments
NPI 1619123353 · GRANITE CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 16 payments from 7 companies in 2025. Trend: 2023 $22 · 2024 $215 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $191 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: COBENFY, INGREZZA, CAPLYTA, INVEGA SUSTENNA, FANAPT, Auvelity, VRAYLAR.
Industry payments across IL — which companies pay providers there.
